Decreased p21 Levels Are Required for Efficient Restart of DNA Synthesis after S Phase Block
Open accessThe DOI matches its Crossref record; 54 of the 55 references it cites were found in a registry or an index.
Abstract
The cyclin-dependent kinase inhibitor p21, a major transcriptional target of the tumor suppressor p53, plays a critical role in cell cycle arrest in G1 and G2 after DNA damage. It was previously shown that in some human cell lines when S phase is arrested, p53 is transcriptionally impaired such that some p53 targets including p21 are only weakly induced. We show here that during S phase arrest proteasome-mediated turnover of p21 is significantly increased in a manner that is independent of p53. It is well established that p21 can interact both with cyclin-dependent kinase complexes and with proliferating cell nuclear antigen (PCNA). Interestingly, the scant amount of p21 detected during S phase block cannot fully saturate cyclin A-cyclin-dependent kinase 2 complexes and does not interact detectably with PCNA. Importantly, DNA elongation assays in isolated nuclei show that the C terminus of p21 containing the PCNA-binding domain effectively blocks this process. This implies that p21 down-regulation could be an essential requirement for efficient restart of DNA synthesis. In line with this, only cells expressing low levels of p21 immediately progress through the cell cycle upon release from S phase arrest, whereas the remaining few high p21 producing cells move much more slowly through S. Thus, p21 down-regulation is multiply determined and is required for the reversibility of the arrest in S phase.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“While the p21/PCNA ratio was reported to never exceed a 1:1 ratio in cells [37,38], a ratio of at least 10:1 is required to block DNA repair by nucleotide excision repair (NER) in vitro [38,39,40,41].”
From CDK-Independent and PCNA-Dependent Functions of p21 in DNA Replication (2020) · cites this paper as [37]
Citations
Cites
DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2
Shieh, S.-Y., Ikeda, M., Taya, Y., & Prives, C. (1997) · Cell · doi:10.1016/s0092-8674(00)80416-x · Cited by 2,100
Self-citationThe p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA
Waga, S., Hannon, G. J., Beach, D., & Stillman, B. (1994) · Nature · doi:10.1038/369574a0 · Cited by 1,655
Liu, Q., Guntuku, S., Cui, X.-S., Matsuoka, S., Cortez, D., Tamai, K., Luo, G., Carattini-Rivera, S., DeMayo, F., Bradley, A., et al. (2000) · Genes & Development · doi:10.1101/gad.14.12.1448 · Cited by 1,625
The complexity of p53 modulation: emerging patterns from divergent signals
Giaccia, A. J., & Kastan, M. B. (1998) · Genes & Development · doi:10.1101/gad.12.19.2973 · Cited by 1,314
p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage.
Macleod, K. F., Sherry, N., Hannon, G., Beach, D., Tokino, T., Kinzler, K., Vogelstein, B., & Jacks, T. (1995) · Genes & Development · doi:10.1101/gad.9.8.935 · Cited by 1,119
Aphidicolin prevents mitotic cell division by interfering with the activity of DNA polymerase-α
IKEGAMI, S., TAGUCHI, T., OHASHI, M., OGURO, M., NAGANO, H., & MANO, Y. (1978) · Nature · doi:10.1038/275458a0 · Cited by 907
Differential effects by the p21 CDK inhibitor on PCNA-dependent DNA replication and repair
Li, R., Waga, S., Hannon, G. J., Beach, D., & Stillman, B. (1994) · Nature · doi:10.1038/371534a0 · Cited by 643
Essential role of BETA2/NeuroD1 in development of the vestibular and auditory systems
Liu, M., Pereira, F. A., Price, S. D., Chu, M.-J., Shope, C., Himes, D., Eatock, R. A., Brownell, W. E., Lysakowski, A., & Tsai, M.-J. (2000) · Genes & Development · doi:10.1101/gad.840500 · Cited by 625
Separate domains of p21 involved in the inhibition of Cdk kinase and PCNA
Chen, J., Jackson, P. K., Kirschner, M. W., & Dutta, A. (1995) · Nature · doi:10.1038/374386a0 · Cited by 548
Role of the SCFSkp2 Ubiquitin Ligase in the Degradation of p21Cip1 in S Phase
Bornstein, G., Bloom, J., Sitry-Shevah, D., Nakayama, K., Pagano, M., & Hershko, A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301774200 · Cited by 494
Cyclin-dependent kinases prevent DNA re-replication through multiple mechanisms
Nguyen, V. Q., Co, C., & Li, J. J. (2001) · Nature · doi:10.1038/35082600 · Cited by 462
Ashcroft, M., & Vousden, K. H. (1999) · Oncogene · doi:10.1038/sj.onc.1203012 · Cited by 415
Human CUL-1 associates with the SKP1/SKP2 complex and regulates p21 CIP1/WAF1 and cyclin D proteins
Yu, Z.-K., Gervais, J. L. M., & Zhang, H. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.19.11324 · Cited by 411
Proteasomal Turnover of p21Cip1 Does Not Require p21Cip1 Ubiquitination
Sheaff, R. J., Singer, J. D., Swanger, J., Smitherman, M., Roberts, J. M., & Clurman, B. E. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)80435-9 · Cited by 382
Adams, P. D., Sellers, W. R., Sharma, S. K., Wu, A. D., Nalin, C. M., & Kaelin, W. G. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.12.6623 · Cited by 373
Dahmann, C., Diffley, J. F. X., & Nasmyth, K. A. (1995) · Current Biology · doi:10.1016/s0960-9822(95)00252-1 · Cited by 362
Stress Signals Utilize Multiple Pathways To Stabilize p53
Ashcroft, M., Taya, Y., & Vousden, K. H. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.9.3224-3233.2000 · Cited by 356
Koumenis, C., Alarcon, R., Hammond, E., Sutphin, P., Hoffman, W., Murphy, M., Derr, J., Taya, Y., Lowe, S. W., Kastan, M., et al. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.4.1297-1310.2001 · Cited by 346
Characterization of homologous recombination induced by replication inhibition in mammalian cells
Saintigny, Y. (2001) · The EMBO Journal · doi:10.1093/emboj/20.14.3861 · Cited by 334
Proteasome-Mediated Degradation of p21 via N-Terminal Ubiquitinylation
Bloom, J., Amador, V., Bartolini, F., DeMartino, G., & Pagano, M. (2003) · Cell · doi:10.1016/s0092-8674(03)00755-4 · Cited by 322
Cyclin-Binding Motifs Are Essential for the Function of p21 CIP1
Chen, J., Saha, P., Kornbluth, S., Dynlacht, B. D., & Dutta, A. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.9.4673 · Cited by 320
Cyclin/Cdk-Dependent Initiation of DNA Replication in a Human Cell-Free System
Krude, T., Jackman, M., Pines, J., & Laskey, R. A. (1997) · Cell · doi:10.1016/s0092-8674(00)81863-2 · Cited by 310
Ubiquitination of p53 and p21 Is Differentially Affected by Ionizing and UV Radiation
Maki, C. G., & Howley, P. M. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.1.355 · Cited by 308
Hammond, E. M., Dorie, M. J., & Giaccia, A. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212360200 · Cited by 284
Di Cunto, F., Topley, G., Calautti, E., Hsiao, J., Ong, L., Seth, P. K., & Dotto, G. P. (1998) · Science · doi:10.1126/science.280.5366.1069 · Cited by 275
UV Irradiation Triggers Ubiquitin-Dependent Degradation of p21WAF1 to Promote DNA Repair
Bendjennat, M., Boulaire, J., Jascur, T., Brickner, H., Barbier, V., Sarasin, A., Fotedar, A., & Fotedar, R. (2003) · Cell · doi:10.1016/j.cell.2003.08.001 · Cited by 248
Touitou, R. (2001) · The EMBO Journal · doi:10.1093/emboj/20.10.2367 · Cited by 236
Timson, J. (1975) · Mutation Research/Reviews in Genetic Toxicology · doi:10.1016/0165-1110(75)90002-0 · Cited by 236
Proteasome-Dependent Regulation of p21WAF1/CIP1Expression
Blagosklonny, M. V., Wu, G. S., Omura, S., & El-Deiry, W. S. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.1546 · Cited by 221
WAF1 retards S-phase progression primarily by inhibition of cyclin-dependent kinases
Ogryzko, V. V., Wong, P., & Howard, B. H. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.8.4877 · Cited by 193
Krude, T. (1999) · Experimental Cell Research · doi:10.1006/excr.1998.4342 · Cited by 183
p53 Down-Regulates CHK1 through p21 and the Retinoblastoma Protein
Gottifredi, V., Karni-Schmidt, O., Shieh, S.-Y., & Prives, C. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.4.1066-1076.2001 · Cited by 172
Self-citationBall, K. L., Laín, S., Fåhræus, R., Smythe, C., & Lane, D. P. (1997) · Current Biology · doi:10.1016/s0960-9822(06)00029-7 · Cited by 171
Baptiste, N., Friedlander, P. A., Chen, X., & Prives, C. L. (2002) · Oncogene · doi:10.1038/sj.onc.1205015 · Cited by 168
Self-citationColeman, M. L., Marshall, C. J., & Olson, M. F. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg189 · Cited by 164
Inhibition of nucleotide excision repair by the cyclin-dependent kinase inhibitor p21
Pan, Z.-Q., Reardon, J. T., Li, L., Flores-Rozas, H., Legerski, R., Sancar, A., & Hurwitz, J. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.37.22008 · Cited by 151
McKinney, K., & Prives, C. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.19.6797-6808.2002 · Cited by 147
Self-citationp53 accumulates but is functionally impaired when DNA synthesis is blocked
Gottifredi, V., Shieh, S.-Y., Taya, Y., & Prives, C. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.3.1036 · Cited by 147
Self-citationPodust, V. N., Podust, L. M., Goubin, F., Ducommun, B., & Huebscher, U. (1995) · Biochemistry · doi:10.1021/bi00027a039 · Cited by 124
Chen, U., Chen, S., Saha, P., & Dutta, A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.21.11597 · Cited by 121
DNA replication: Building the perfect switch
Diffley, J. F. X. (2001) · Current Biology · doi:10.1016/s0960-9822(01)00196-8 · Cited by 105
Activation of cyclin D1-kinase in murine fibroblasts lacking both p21Cip1 and p27Kip1
Sugimoto, M., Martin, N., Wilks, D. P., Tamai, K., Huot, T. J. G., Pantoja, C., Okumura, K., Serrano, M., & Hara, E. (2002) · Oncogene · doi:10.1038/sj.onc.1206019 · Cited by 94
Prolonged arrest of mammalian cells at the G1/S boundary results in permanent S phase stasis
Borel, F., Lacroix, F. B., & Margolis, R. L. (2002) · Journal of Cell Science · doi:10.1242/jcs.115.14.2829 · Cited by 81
The C-terminal domain of p21 inhibits nucleotide excision repair In vitro and In vivo
Cooper, M. P., Balajee, A. S., & Bohr, V. A. (1999) · Molecular Biology of the Cell · doi:10.1091/mbc.10.7.2119 · Cited by 80
Cyclin-Dependent Kinase Inhibitor p21 Modulates the DNA Primer-Template Recognition Complex
Waga, S., & Stillman, B. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.7.4177 · Cited by 78
Oku, T., Ikeda, S., Sasaki, H., Fukuda, K., Morioka, H., Ohtsuka, E., Yoshikawa, H., & Tsurimoto, T. (1998) · Genes to Cells · doi:10.1046/j.1365-2443.1998.00199.x · Cited by 77
Regulation of BRCA1 by protein degradation
Blagosklonny, M. V., An, W. G., Melillo, G., Nguyen, P., Trepel, J. B., & Neckers, L. Μ. (1999) · Oncogene · doi:10.1038/sj.onc.1203068 · Cited by 69
Activity and nature of p21 WAF1 complexes during the cell cycle
Cai, K., & Dynlacht, B. D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.21.12254 · Cited by 63
Krude, T. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.18.13699 · Cited by 59
Li, A., & Blow, J. J. (2001) · Nature Cell Biology · doi:10.1038/35087119 · Cited by 52
Seek and Destroy: SCF Ubiquitin Ligases in Mammalian Cell Cycle Control
Spruck, C., & Strohmaier, H. M. (2002) · Cell Cycle · doi:10.4161/cc.1.4.132 · Cited by 51
Komarova, E. A., Zelnick, C. R., Chin, D., Zeremski, M., Gleiberman, A. S., Bacus, S. S., & Gudkov, A. V. (1997) · PubMed · Cited by 45
Skildum, A. J., Mukherjee, S., & Conrad, S. E. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109179200 · Cited by 42
Cellular senescence and cancer
(1999) · doi:10.1002/(sici)1096-9896(199901)187:1
Self-citation
Research works printed but not linked: 2
- Dotto, 2000, Biochim. Biophys. Acta, 1471, M43
- Komarova, 1997, Cancer Res., 57, 5217
Cited by
Multiple roles of the cell cycle inhibitor p21CDKN1A in the DNA damage response
Cazzalini, O., Scovassi, A. I., Savio, M., Stivala, L. A., & Prosperi, E. (2010) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2010.01.009 · Cited by 433
Dutto, I., Tillhon, M., Cazzalini, O., Stivala, L. A., & Prosperi, E. (2015) · Archives of Toxicology · doi:10.1007/s00204-014-1430-4 · Cited by 236
Al Bitar, S., & Gali-Muhtasib, H. (2019) · Cancers · doi:10.3390/cancers11101475 · Cited by 224
H2AX Is Required for Cell Cycle Arrest via the p53/p21 Pathway
Fragkos, M., Jurvansuu, J., & Beard, P. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.01830-08 · Cited by 170
p53: Twenty five years understanding the mechanism of genome protection
Gómez-Lázaro, M., Fernández-Gómez, F.-J., & Jordán, J. (2004) · Journal of Physiology and Biochemistry · doi:10.1007/bf03167075 · Cited by 134
Metadata
- Authors
- Gottifredi, V., McKinney, K., Poyurovsky, M. V., & Prives, C.
- Affiliations
- Columbia University (US)
- Corresponding author
- Prives, Carol
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2004-02
- Volume
- 279
- Issue
- 7
- Pages
- 5802-5810
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2161467578
- Cited by
- 76
- References
- 55
- Citations by year
- 2026: 3 · 2025: 2 · 2024: 1 · 2022: 1 · 2021: 3 · 2020: 4 · 2019: 7 · 2018: 2 · 2017: 1 · 2016: 4 · 2015: 1 · 2014: 5 · 2013: 4 · 2012: 6
- FWCI
- 2.88
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6077 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (CA 58316)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Keywords
- p21, S phase arrest, proteasomal degradation, p53-independent regulation, CDK2, cyclin A, proliferating cell nuclear antigen, DNA elongation, cell cycle checkpoints
- MeSH terms
- Cell Nucleus, Cysteine Endopeptidases, DNA, Humans, Hydroxyurea, Models, Biological, Multienzyme Complexes, Recombinant Proteins, Time Factors, Transcription, Genetic, Blotting, Northern, Down-Regulation, Tumor Suppressor Protein p53, G1 Phase, G2 Phase, S Phase, Cyclins, Protein Structure, Tertiary, Proliferating Cell Nuclear Antigen, Cyclin A, Cell Line, Tumor, Proteasome Endopeptidase Complex, Cyclin-Dependent Kinase Inhibitor p21
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.